These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33523584)

  • 1. A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.
    Lecchi M; Verderio P; Cappelletti V; De Santis F; Paolini B; Monica M; Sangaletti S; Pupa SM; Iorio MV; Bianchi G; Gennaro M; Fucà G; De Braud F; Tagliabue E; Di Nicola M
    Mol Oncol; 2021 May; 15(5):1345-1357. PubMed ID: 33523584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
    Triulzi T; Casalini P; Sandri M; Ratti M; Carcangiu ML; Colombo MP; Balsari A; Ménard S; Orlandi R; Tagliabue E
    PLoS One; 2013; 8(2):e56761. PubMed ID: 23441215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.
    Callari M; Musella V; Di Buduo E; Sensi M; Miodini P; Dugo M; Orlandi R; Agresti R; Paolini B; Carcangiu ML; Cappelletti V; Daidone MG
    Mol Oncol; 2014 Oct; 8(7):1278-89. PubMed ID: 24853384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrared Spectroscopic Imaging Visualizes a Prognostic Extracellular Matrix-Related Signature in Breast Cancer.
    Tiwari S; Triulzi T; Holton S; Regondi V; Paolini B; Tagliabue E; Bhargava R
    Sci Rep; 2020 Mar; 10(1):5442. PubMed ID: 32214177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment.
    Rybinska I; Sandri M; Bianchi F; Orlandi R; De Cecco L; Gasparini P; Campiglio M; Paolini B; Sfondrini L; Tagliabue E; Triulzi T
    Cells; 2020 Feb; 9(2):. PubMed ID: 32069815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer.
    Winslow S; Lindquist KE; Edsjö A; Larsson C
    BMC Cancer; 2016 Nov; 16(1):841. PubMed ID: 27809802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
    Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
    Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.
    Zerdes I; Sifakis EG; Matikas A; Chrétien S; Tobin NP; Hartman J; Rassidakis GZ; Bergh J; Foukakis T
    Mol Oncol; 2020 May; 14(5):951-963. PubMed ID: 32115850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
    Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
    Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
    Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.
    Karn T; Pusztai L; Holtrich U; Iwamoto T; Shiang CY; Schmidt M; Müller V; Solbach C; Gaetje R; Hanker L; Ahr A; Liedtke C; Ruckhäberle E; Kaufmann M; Rody A
    PLoS One; 2011; 6(12):e28403. PubMed ID: 22220191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk.
    Yau C; Sninsky J; Kwok S; Wang A; Degnim A; Ingle JN; Gillett C; Tutt A; Waldman F; Moore D; Esserman L; Benz CC
    Breast Cancer Res; 2013; 15(5):R103. PubMed ID: 24172169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes.
    Pezzè L; Meškytė EM; Forcato M; Pontalti S; Badowska KA; Rizzotto D; Skvortsova II; Bicciato S; Ciribilli Y
    Cell Death Dis; 2021 Jul; 12(8):742. PubMed ID: 34315857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis.
    Wang DY; Done SJ; McCready DR; Boerner S; Kulkarni S; Leong WL
    Breast Cancer Res; 2011 Sep; 13(5):R92. PubMed ID: 21939527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer.
    Kwon MJ
    Arch Pharm Res; 2019 Nov; 42(11):947-961. PubMed ID: 31707598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
    Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
    Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
    Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading breast cancer tissues using molecular portraits.
    Olsson N; Carlsson P; James P; Hansson K; Waldemarson S; Malmström P; Fernö M; Ryden L; Wingren C; Borrebaeck CA
    Mol Cell Proteomics; 2013 Dec; 12(12):3612-23. PubMed ID: 23982162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.